[09/02/20]
Posted on September 2, 2020 in Health Law News, Litigation Analysis
Published by: Hall Render
The United States Court of Appeals, Eleventh Circuit, recently issued an opinion reaffirming the need for counsel in qui tam cases under the False Claims Act (“FCA”). In particular, pro se plaintiffs, or individuals proceeding without attorney representation, filed suit against multiple defendants alleging qui tam claims under the FCA as well as 21... READ MORE
Tags: False Claims Act, FCA, qui tam
[07/29/20]
Posted on July 29, 2020 in Health Law News
Published by: Hall Render
On July 8, 2020, the Department of Justice announced it settled a qui tam action[1] involving alleged violations of the federal and state False Claims Act (“FCA”) for $72.3 million against an Oklahoma surgical specialty hospital, its managers, a physician group and two individual physicians. Part of the factual allegations underpinning the FCA claims... READ MORE
Tags: Anti-Kickback Statute, False Claims Act, FCA, Health Care Real Estate, qui tam, Stark law
[04/04/19]
Posted on April 4, 2019 in False Claims Act Defense
Published by: Hall Render
In a recent case out of Kansas, the Tenth Circuit reiterated the importance of the FCA’s materiality and scienter requirements that the Supreme Court set forth in Escobar: FCA claims must satisfy materiality and knowledge requirements—both of which are rigorous and strictly enforced. A whistleblower must prove knowledge in an implied certification case—it cannot... READ MORE
Tags: FCA, materiality, qui tam, Scienter, Tenth Circuit, U.S. ex rel. Coffman v. The City of Leavenworth KS, whistleblower
[01/09/19]
Posted on January 9, 2019 in Health Law News
Published by: Hall Render
The Department of Justice (“DOJ”) reported it collected more than $2.8 billion in False Claims Act (“FCA”) settlements and verdicts in 2018.¹ This is significantly down from the record $5.69 billion recovered in 2014 and from the $3.6 billion – $4.7 billion in 2015 through 2017. This can primarily be explained by the absence... READ MORE
Tags: DOJ, FCA, health care fraud, qui tam, whistleblower
[10/30/18]
Posted on October 30, 2018 in False Claims Act Defense
Published by: Hall Render
The Fifth Circuit ruled that a whistleblower’s voluntary dismissal with prejudice cannot affect the Government’s ability to pursue related litigation. When the Government has not yet intervened, and thus is not a yet a party, a case cannot be dismissed with prejudice as to the Government by a whistleblower. Background In Vaughn, ex rel.... READ MORE
Tags: AKS, Anti-Kickback Statute, False Claims Act, FCA, Fifth Circuit, Northern District of Georgia, qui tam, Southern District of Texas, Vaughn ex rel. v. United Biologics, Voluntary Dismissal with Prejudice, whistleblower
[10/19/18]
Posted on October 19, 2018 in False Claims Act Defense
Published by: Hall Render
The Eleventh Circuit recently held that a qui tam relator cannot intervene in criminal forfeiture proceedings when the Government chooses to criminally prosecute fraud rather than intervene in a qui tam action. In United States v. Couch,[1] a former employee (“Relator”) of a pain management clinic in Alabama tried to recover amounts she believed... READ MORE
Tags: Criminal Forfeiture, Eleventh Circuit, False Claims Act, FCA, qui tam, relator, United States v. Couch
[04/17/18]
Posted on April 17, 2018 in False Claims Act Defense
Published by: Hall Render
On April 11, 2018, the Eleventh Circuit Court of Appeals split from the Fourth and Tenth Circuits when it issued an order effectively granting relators in qui tam actions an additional three years to file. The court ruled that § 3731(b)(2)’s three-year limitation, which has traditionally only been applied when the United States is... READ MORE
Tags: Eleventh Circuit, False Claims Act, FCA Statute of Limitations, Hunt v. Cochise Consultancy, qui tam
[01/15/18]
Posted on January 15, 2018 in False Claims Act Defense
Published by: Hall Render
In an opinion loaded with linguistic hooks, the United States District Court for the Middle District of Florida recently reinforced the Supreme Court’s holding in Escobar, enthusiastically highlighting the importance of materiality and scienter in FCA cases. Background In U.S. ex rel. Ruckh v. Salus Rehabilitation, LLC, et al., Relators were successful in a... READ MORE
Tags: analysis, False Claims Act, FCA, Litigation, qui tam
[10/17/17]
Posted on October 17, 2017 in False Claims Act Defense
Published by: Hall Render
The Fifth Circuit recently addressed pre-suit disclosure and causation requirements for FCA theories of liability in United States ex rel. King v. Solvay Pharmaceuticals Inc., 871 F.3d 318 (5th Cir. 2017). Two former employees (“Relators”) of Solvay Pharmaceuticals, Inc. filed a qui tam suit claiming that Solvay induced false Medicaid claims through a variety... READ MORE
Tags: analysis, False Claims Act, FCA, Litigation, qui tam
[05/28/15]
Posted on May 28, 2015 in False Claims Act Defense
Published by: Hall Render
On May 26, 2015, the United States Supreme Court issued its decision in Kellog Brown & Root Service, Inv. et al. v. United States ex rel. Carter, 575 U.S. ____ (2015), Case No. 12-1497. Most of the commentary on the case centers around the Court’s decision on the Wartime Suspension of Limitations Act, but... READ MORE
Tags: bar, Brown, Carter, False Claims Act, FCA, first to file, Kellogg, original source, prejudice, public disclosure, qui tam, Root, Settlement, whistleblower